SEC 13F Intelligence

Frazier Management LLC / MIRM

Frazier Management LLC’s Mirum Pharmaceuticals Inc Position

Does Frazier Management LLC own Mirum Pharmaceuticals Inc (MIRM)? Not currently — the last reported position was 3.57M shares worth $57M in Q4 2021; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$57M
Q4 2021
Shares
3.57M
% of Portfolio
+4.38%
Quarters Held
10
position exited

Position History MIRM

Reported value by quarter
Q3 ’19: $36MQ3 ’19Q4 ’19: $87MQ1 ’20: $50MQ1 ’20Q2 ’20: $69MQ3 ’20: $69MQ3 ’20Q4 ’20: $62MQ1 ’21: $71MQ1 ’21Q2 ’21: $62MQ3 ’21: $71MQ3 ’21Q4 ’21: $57Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q4 20213.57M$57M+4.38%
Q3 20213.57M$71M+5.69%
Q2 20213.57M$62M+5.69%
Q1 20213.57M$71M+5.67%
Q4 20203.57M$62M+4.80%
Q3 20203.57M$69M+6.17%
Q2 20203.57M$69M+6.10%
Q1 20203.57M$50M+5.66%
Q4 20193.57M$87M+14.67%
Q3 20193.57M$36M+11.22%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Frazier Management LLC’s full portfolio or all institutional holders of MIRM.